Deutsche Bank’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-609,809
| Closed | -$2.07M | – | 5641 |
|
|
2018
Q3 | $2.07M | Buy |
609,809
+324,464
| +114% | +$1.17M | ﹤0.01% | 2831 |
|
|
2018
Q2 | $1.07M | Sell |
285,345
-19,377
| -6% | -$94.3K | ﹤0.01% | 3375 |
|
|
2018
Q1 | $1.25M | Buy |
304,722
+98,789
| +48% | +$460K | ﹤0.01% | 3178 |
|
|
2017
Q4 | $956K | Buy |
205,933
+104,585
| +103% | +$576K | ﹤0.01% | 3219 |
|
|
2017
Q3 | $718K | Buy |
101,348
+2,972
| +3% | +$21.4K | ﹤0.01% | 3216 |
|
|
2017
Q2 | $710K | Buy |
98,376
+75,032
| +321% | +$469K | ﹤0.01% | 3245 |
|
|
2017
Q1 | $142K | Sell |
23,344
-37,161
| -61% | -$204K | ﹤0.01% | 3761 |
|
|
2016
Q4 | $353K | Sell |
60,505
-104,357
| -63% | -$570K | ﹤0.01% | 3383 |
|
|
2016
Q3 | $873K | Buy |
164,862
+10,167
| +7% | +$54.8K | ﹤0.01% | 2902 |
|
|
2016
Q2 | $1.02M | Buy |
154,695
+133,316
| +624% | +$745K | ﹤0.01% | 2868 |
|
|
2016
Q1 | $98K | Sell |
21,379
-26,594
| -55% | -$106K | ﹤0.01% | 4027 |
|
|
2015
Q4 | $240K | Sell |
47,973
-294,829
| -86% | -$1.4M | ﹤0.01% | 3631 |
|
|
2015
Q3 | $1.21M | Buy |
342,802
+169,299
| +98% | +$1.13M | ﹤0.01% | 2823 |
|
|
2015
Q2 | $1.73M | Buy |
173,503
+105,068
| +154% | +$1.13M | ﹤0.01% | 2580 |
|
|
2015
Q1 | $868K | Sell |
68,435
-152,952
| -69% | -$1.97M | ﹤0.01% | 2954 |
|
|
2014
Q4 | $3.13M | Sell |
221,387
-22,839
| -9% | -$354K | ﹤0.01% | 2325 |
|
|
2014
Q3 | $3.35M | Buy |
244,226
+184,631
| +310% | +$2.83M | ﹤0.01% | 2118 |
|
|
2014
Q2 | $914K | Sell |
59,595
-14,270
| -19% | -$202K | ﹤0.01% | 3014 |
|
|
2014
Q1 | $1.26M | Sell |
73,865
-13,472
| -15% | -$203K | ﹤0.01% | 2707 |
|
|
2013
Q4 | $1.13M | Sell |
87,337
-822,858
| -90% | -$9.83M | ﹤0.01% | 2590 |
|
|
2013
Q3 | $9.18M | Buy |
910,195
+820,648
| +916% | +$7.3M | 0.01% | 1385 |
|
|
2013
Q2 | $667K | Buy |
+89,547
| New | +$700K | ﹤0.01% | 2984 |
|
Deutsche Bank's KERX Position: Q4 2018 in Review
Deutsche Bank sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 609,809 shares — an estimated $2.07M sold.
Deutsche Bank first reported a position in KERX in Q2 2013 and held it in 22 quarters. The position peaked at $9.18M in Q3 2013. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- Deutsche Bank reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- Deutsche Bank sold 609,809 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $2.07M.
- Deutsche Bank first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 22 quarters.
- Deutsche Bank's Keryx Biopharmaceuticals Inc position peaked at $9.18M in Q3 2013.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on Deutsche Bank's 13F filing for Q4 2018, filed 14 Feb 2019.